Halozyme Therapeutics, Inc. (NASDAQ:HALO) Expands Delivery Platform, Poised For Near-Term Revenue Lift
![]() |
Strong corporate moves and a growing royalty base position Halozyme for continued top-line momentum, while short-term technical indicators signal pressure that could temper near-term upside. |









